Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
PHARMACEUTICAL
CHALLENGES IN
AFRICA
By ADIL ZANFARI, PRESIDENT
EAHIC London

1
FROM AFRICANS TO AFRICANS
A PRAGMATIC VISION ABOUT THE FUTURE OF
PHARMACEUTICAL INDUSTRY IN AFRICA
THE MOROCCAN CASE
The Moroccan Pharmaceutical Market:
a high potential industry in motion
•
•
•
•

32 pharmaceuticals industrial
plants
300 ...
The EMERGENCE Plan: the Morocco
Government industrial strategy to
strengthen country attractiveness
• Launched in 2007 to ...
The Pharmaceutical industry is now
fully part of the strategic investment plan

Moroccan Government
Pharmacists

Medical D...
The EMERGENCE Plan for Pharmaceutical
industry: a collective & focused approach
to unleash the local potential
 Partnersh...
The Pharmaceutical EMERGENCE plan
translates into a multidimensional approach
to improve National health system
Strengthen...
The Pharmaceutical EMERGENCE plan is
also seeking growth through targeting 4 key
segments representing a total potential o...
In fact the Pharmaceutical EMERGENCE
plan constitutes a strong lever to
accelerate cost effective achievement of
competiti...
254 – 260 ZI 24000 EL JADIDA MOROCCO
Tel : +212 523 35 29 83
FAX: +212 523 35 29 93

www.genpharma.ma

11
Pharmaceutical challenges in Africa
Upcoming SlideShare
Loading in …5
×
Upcoming SlideShare
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and Pharmaceutical Sector
Next
Download to read offline and view in fullscreen.

2

Share

Download to read offline

Pharmaceutical challenges in Africa

Download to read offline

Presentation by Adil Zanfari, President, Genpharma, Morocco made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

Related Books

Free with a 30 day trial from Scribd

See all

Pharmaceutical challenges in Africa

  1. 1. PHARMACEUTICAL CHALLENGES IN AFRICA By ADIL ZANFARI, PRESIDENT EAHIC London 1
  2. 2. FROM AFRICANS TO AFRICANS A PRAGMATIC VISION ABOUT THE FUTURE OF PHARMACEUTICAL INDUSTRY IN AFRICA THE MOROCCAN CASE
  3. 3. The Moroccan Pharmaceutical Market: a high potential industry in motion • • • • 32 pharmaceuticals industrial plants 300 millions units manufactured in 2011 6000 products presentations marketed 65% of total medicines consumed are produced locally • + 40 000 direct and indirect employment • 2012 Private market : 1 billion USD • 2013 Tender market : 300 millions USD • 2011 Export pharmaceutical market : 45 millions USD • 40 export Countries in Africa, Middle East, Europe • Morocco included into the European pharmaceutical Zone • EDMQ European Pharmacopoeia applied • Morocco National Control Laboratory ( LNCM ) is the only African member of the European network of official medecine Control laboratories ( OMCLs EDMQ )
  4. 4. The EMERGENCE Plan: the Morocco Government industrial strategy to strengthen country attractiveness • Launched in 2007 to magnify the competitive advantages of Morocco over other developing countries • 2 Main strategic goals:  Accelerate the creation of sustainable added value wealth  Build up powerful industrial activities to boost-up exports • 8 specific industries covered:         Offshoring Automotive Electronics Aeronautic Agro food textile / leather Pharmaceutical Industry Chemistry KEY ISSUE => PHARMACEUTICAL INDUSTRY IS INCLUDED SINCE 20 FEBRUARY 2013
  5. 5. The Pharmaceutical industry is now fully part of the strategic investment plan Moroccan Government Pharmacists Medical Doctors National Association of Generic Pharmaceutical Producers PHARMACEUTICAL INDUSTRY HAS BEEN ADDED IN THE EMERGENCE PLAN IN 2013 !
  6. 6. The EMERGENCE Plan for Pharmaceutical industry: a collective & focused approach to unleash the local potential  Partnership between Private sector & Public sector  First class international and national consulting firms involved  One strong Objective: Develop access to affordable medicines  Key Target : Accelerate both local market growth and export development  Milestone 1: Achieve 1 to 2 billion USD sales in Pharma Export by 2023  Milestone 2: Increase local pharma market from 1 to 2 billion USD by 2023  Targeted outcome 1: Create + 5,000 additional direct employement  Targeted outcome 2: Create + 15,000 – 20,000 indirect employement
  7. 7. The Pharmaceutical EMERGENCE plan translates into a multidimensional approach to improve National health system Strengthen & upgrade the local pharmaceutical industry to match USD FDA, AFSAPS, TGA, UK MHRA, MCC & GCC certifications Develop outsourcing R&D Main Goal: Strengthen the ability of National Health system to address the needs of Moroccan population Develop Clinical trials programs (CRO) Launch large scale training & education of pharma teams Increase impact of Generics through Export to Africa & Middle East Develop Manufacturing offshoring (CMO) Dedicate investment funds to sponsor the project (100 M USD) Upgrade local legislation to match European pharma rules Attract mid size Pharma companies to relocate production in Morocco
  8. 8. The Pharmaceutical EMERGENCE plan is also seeking growth through targeting 4 key segments representing a total potential of 100 Million USD
  9. 9. In fact the Pharmaceutical EMERGENCE plan constitutes a strong lever to accelerate cost effective achievement of competitive economy of scale ECONOMY OF SCALE: A KEY INGREDIENT TO SECURE AFFORDABLE DRUGS TO POPULATION !
  10. 10. 254 – 260 ZI 24000 EL JADIDA MOROCCO Tel : +212 523 35 29 83 FAX: +212 523 35 29 93 www.genpharma.ma 11
  • farissalama

    Oct. 7, 2018
  • miqbalwajid

    Sep. 24, 2018

Presentation by Adil Zanfari, President, Genpharma, Morocco made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

Views

Total views

4,629

On Slideshare

0

From embeds

0

Number of embeds

86

Actions

Downloads

234

Shares

0

Comments

0

Likes

2

×